NorthStar Medical Radioisotopes Provides Updates on Corporate Progress and Upcoming Milestones
NorthStar’s Mo-99 program continues at the forefront of U.S. radioisotope production as the only commercialized producer of key medical radioisotopes molybdenum-99 (Mo-99)/technetium-99m (Tc-99m
United States University Of Missouri Eckert Ziegler Radiopharm Theranostics Frank Scholz Stephen Merrick
Source: itnonline.com